Stay updated with breaking news from Vishala patel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers. ....
QTORIN™ rapamycin has potential to become first approved therapy and standard of care for Microcystic Lymphatic Malformations in U.S.; significant commercial opportunity based on an estimated more than 30,000 individuals ....
Survey questions included how respondents would use AI to help their patients, and how they felt about non-dermatologists using AI to detect skin lesions. ....